Concepedia

Leon Buchinger

LB

2

Publications

75

Citations

2

H-Index

2022

Active since

Affiliations

Miltenyi Biotec (Germany)(Current)

University of Freiburg

German Cancer Research Center

University Hospital Frankfurt

Frankfurt Cancer Institute

Leon Buchinger is an author at Miltenyi Biotec (Germany) specializing in cell biology, natural killer cells, and crispr.

Top concepts

Publications per year

2022–2024

2

Publications

2

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Tobias Bexte, Nawid Albinger, Ahmad Al Ajami et al. · Nature Communications · 2024 · 54 citations · Full text

, , +7

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Nawid Albinger, Tobias Bexte, Leon Buchinger et al. · Blood · 2022 · 21 citations

Rows per page

1–2 of 2